M&A

Gilead closer and closer to acquiring Galapagos (€3.96bn)
GoinPharma
Sun, 12/17/17 - 10:27 am
Gilead Sciences
Galapagos
M&A
Here's Why GlycoMimetics Could Become a Takeover Target
Yahoo/Motley Fool
Sun, 12/17/17 - 11:36 am
GlycoMimetics
M&A
GMI-1271
AML
acute myeloid leukemia
Pfizer
8 Takeout targets to watch in 2018
BioPharma Dive
Sat, 12/16/17 - 08:41 am
M&A
Allergan
Alnylam
Biomarin
Bristol-Myers Squibb
Incyte
Madrigal Pharmaceuticals
Spark Therapeutics
Sucampo
Don't Count on Gilead Buying Galapagos
Bloomberg
Sat, 12/16/17 - 08:35 am
Gilead Sciences
Galapagos
M&A
Express Scripts Will Seek 'Targeted Acquisitions' To Bolster Business
Forbes
Thu, 12/14/17 - 11:54 am
Express Scripts
M&A
[forum discussion]A bad move by Allergan
Cafepharma Message Boards
Wed, 12/13/17 - 09:50 am
Allergan
Repros
M&A
5 Biotech Buyout Candidates for 2018
Yahoo/Motley Fool
Wed, 12/13/17 - 09:36 am
biotech
M&A
Biogen
Biomarin
Bluebird Bio
Geron
SAGE Therapeutics
Allergan buys an ailing Repros, bagging a women’s health drug for the pipeline
Endpoints
Tue, 12/12/17 - 11:18 am
Allergan
Repros
M&A
Women's Health
M&A slows to a trickle in 2017, but Big Pharma could be on deck for mega deals
Endpoints
Fri, 12/8/17 - 12:01 pm
M&A
Gilead Bets on Cell Therapy Again with $567M Cell Design Labs Deal
Xconomy
Fri, 12/8/17 - 11:57 am
Gilead Sciences
cell therapy
Cell Design Labs
M&A
Stryker Sniffs Out a Tuck-In Opportunity for ENT
Medical Devices and Diagnostics Industry
Fri, 12/8/17 - 11:07 am
Stryker
M&A
ENT
Entellus Medical
devices
Activists threaten to push for a sale of Alexion if execs can’t jack up stock price
Endpoints
Fri, 12/8/17 - 09:58 am
Alexion
M&A
Regulations And Politics Rain On Pharma M&A Parade
Forbes
Thu, 12/7/17 - 01:07 pm
M&A
regulatory
The CVS-Aetna Merger Is A Mortal Threat To U.S. Hospitals
Forbes
Tue, 12/5/17 - 09:39 am
CVS Health
Aetna
M&A
hospitals
Three Takeaways From The CVS-Aetna Merger
Forbes
Mon, 12/4/17 - 11:52 am
CVS Health
Aetna
M&A
PBMs
Novartis looks at offloading its generic pills business in U.S. as market continues to decline
Fierce Pharma
Mon, 12/4/17 - 11:39 am
Novartis
generics
Sandoz
M&A
3 Reasons Pfizer Should Buy Celgene in 2018
Motley Fool
Mon, 12/4/17 - 09:51 am
Pfizer
Celgene
M&A
Deal of the Year: Gilead Buys Kite Pharma
BioPharma Dive
Mon, 12/4/17 - 09:39 am
Gilead Sciences
Kite Pharma
M&A
Nestlé determined to acquire Merck KGaA’s Consumer Health unit
GoinPharma
Mon, 12/4/17 - 09:35 am
Nestle
Merck KGaA
M&A
consumer health
CVS agrees to buy insurance giant Aetna
Stat
Sun, 12/3/17 - 04:03 pm
CVS Health
M&A
Aetna
insurers
PBMs

Pages